523 related articles for article (PubMed ID: 17348023)
1. Mice with GFAP-targeted loss of neurofibromin demonstrate increased axonal MET expression with aging.
Su W; Xing R; Guha A; Gutmann DH; Sherman LS
Glia; 2007 May; 55(7):723-33. PubMed ID: 17348023
[TBL] [Abstract][Full Text] [Related]
2. Glioma formation in neurofibromatosis 1 reflects preferential activation of K-RAS in astrocytes.
Dasgupta B; Li W; Perry A; Gutmann DH
Cancer Res; 2005 Jan; 65(1):236-45. PubMed ID: 15665300
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid proteomic analysis reveals dysregulation of methionine aminopeptidase-2 expression in human and mouse neurofibromatosis 1-associated glioma.
Dasgupta B; Yi Y; Hegedus B; Weber JD; Gutmann DH
Cancer Res; 2005 Nov; 65(21):9843-50. PubMed ID: 16267007
[TBL] [Abstract][Full Text] [Related]
4. Oligodendrogliomas result from the expression of an activated mutant epidermal growth factor receptor in a RAS transgenic mouse astrocytoma model.
Ding H; Shannon P; Lau N; Wu X; Roncari L; Baldwin RL; Takebayashi H; Nagy A; Gutmann DH; Guha A
Cancer Res; 2003 Mar; 63(5):1106-13. PubMed ID: 12615729
[TBL] [Abstract][Full Text] [Related]
5. Astrocyte-targeted expression of interleukin-3 and interferon-alpha causes region-specific changes in metallothionein expression in the brain.
Giralt M; Carrasco J; Penkowa M; Morcillo MA; Santamaría J; Campbell IL; Hidalgo J
Exp Neurol; 2001 Apr; 168(2):334-46. PubMed ID: 11259121
[TBL] [Abstract][Full Text] [Related]
6. Loss of glial fibrillary acidic protein results in decreased glutamate transport and inhibition of PKA-induced EAAT2 cell surface trafficking.
Hughes EG; Maguire JL; McMinn MT; Scholz RE; Sutherland ML
Brain Res Mol Brain Res; 2004 May; 124(2):114-23. PubMed ID: 15135219
[TBL] [Abstract][Full Text] [Related]
7. NF1 regulates a Ras-dependent vascular smooth muscle proliferative injury response.
Xu J; Ismat FA; Wang T; Yang J; Epstein JA
Circulation; 2007 Nov; 116(19):2148-56. PubMed ID: 17967772
[TBL] [Abstract][Full Text] [Related]
8. Nucleophosmin mediates mammalian target of rapamycin-dependent actin cytoskeleton dynamics and proliferation in neurofibromin-deficient astrocytes.
Sandsmark DK; Zhang H; Hegedus B; Pelletier CL; Weber JD; Gutmann DH
Cancer Res; 2007 May; 67(10):4790-9. PubMed ID: 17510408
[TBL] [Abstract][Full Text] [Related]
9. Increased neurofibromatosis 1 gene expression in astrocytic tumors: positive regulation by p21-ras.
Gutmann DH; Giordano MJ; Mahadeo DK; Lau N; Silbergeld D; Guha A
Oncogene; 1996 May; 12(10):2121-7. PubMed ID: 8668337
[TBL] [Abstract][Full Text] [Related]
10. A mouse embryonic stem cell model of Schwann cell differentiation for studies of the role of neurofibromatosis type 1 in Schwann cell development and tumor formation.
Roth TM; Ramamurthy P; Ebisu F; Lisak RP; Bealmear BM; Barald KF
Glia; 2007 Aug; 55(11):1123-33. PubMed ID: 17597122
[TBL] [Abstract][Full Text] [Related]
11. GFAP promoter elements required for region-specific and astrocyte-specific expression.
Lee Y; Messing A; Su M; Brenner M
Glia; 2008 Apr; 56(5):481-93. PubMed ID: 18240313
[TBL] [Abstract][Full Text] [Related]
12. Astrocyte heterogeneity revealed by expression of a GFAP-LacZ transgene.
Lee Y; Su M; Messing A; Brenner M
Glia; 2006 May; 53(7):677-87. PubMed ID: 16482522
[TBL] [Abstract][Full Text] [Related]
13. Increased neurogenesis and astrogenesis from neural progenitor cells grafted in the hippocampus of GFAP-/- Vim-/- mice.
Widestrand A; Faijerson J; Wilhelmsson U; Smith PL; Li L; Sihlbom C; Eriksson PS; Pekny M
Stem Cells; 2007 Oct; 25(10):2619-27. PubMed ID: 17628017
[TBL] [Abstract][Full Text] [Related]
14. [Astrocyte activation and Bcl-2 protein expression induced by lipopolysaccharide in mouse brain].
Deng XH; Liu S; Cai WJ; Lei DL; Luo XG
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Jun; 32(3):401-7. PubMed ID: 17611314
[TBL] [Abstract][Full Text] [Related]
15. Glial fibrillary acidic protein gene promoter is differently modulated by transforming growth factor-beta 1 in astrocytes from distinct brain regions.
Sousa Vde O; Romão L; Neto VM; Gomes FC
Eur J Neurosci; 2004 Apr; 19(7):1721-30. PubMed ID: 15078546
[TBL] [Abstract][Full Text] [Related]
16. GFAP promoter-controlled EGFP-expressing transgenic mice: a tool to visualize astrocytes and astrogliosis in living brain tissue.
Nolte C; Matyash M; Pivneva T; Schipke CG; Ohlemeyer C; Hanisch UK; Kirchhoff F; Kettenmann H
Glia; 2001 Jan; 33(1):72-86. PubMed ID: 11169793
[TBL] [Abstract][Full Text] [Related]
17. GFAP-expressing cells in the postnatal subventricular zone display a unique glial phenotype intermediate between radial glia and astrocytes.
Liu X; Bolteus AJ; Balkin DM; Henschel O; Bordey A
Glia; 2006 Oct; 54(5):394-410. PubMed ID: 16886203
[TBL] [Abstract][Full Text] [Related]
18. Schwann cells from neurofibromin deficient mice exhibit activation of p21ras, inhibition of cell proliferation and morphological changes.
Kim HA; Rosenbaum T; Marchionni MA; Ratner N; DeClue JE
Oncogene; 1995 Jul; 11(2):325-35. PubMed ID: 7624147
[TBL] [Abstract][Full Text] [Related]
19. S100B expression defines a state in which GFAP-expressing cells lose their neural stem cell potential and acquire a more mature developmental stage.
Raponi E; Agenes F; Delphin C; Assard N; Baudier J; Legraverend C; Deloulme JC
Glia; 2007 Jan; 55(2):165-77. PubMed ID: 17078026
[TBL] [Abstract][Full Text] [Related]
20. Expression profiling in tuberous sclerosis complex (TSC) knockout mouse astrocytes to characterize human TSC brain pathology.
Ess KC; Uhlmann EJ; Li W; Li H; Declue JE; Crino PB; Gutmann DH
Glia; 2004 Apr; 46(1):28-40. PubMed ID: 14999811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
